Background: Since the start of the COVID-19 pandemic, racial and ethnic minorities have experienced disparities in infection rates, hospitalization, and death. Monoclonal antibodies (Mab) decrease hospitalization when given to ambulatory non-severe high-risk patients within 10 day of symptom onset. Disparities in care related to Mabs are not well understood. We describe experience from Mab infusion [...]